Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery.
Saved in:
| Title: | Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery. |
|---|---|
| Authors: | Pretorius M (AUTHOR), Murray KT (AUTHOR), Yu C (AUTHOR), Byrne JG (AUTHOR), Billings FT 4th (AUTHOR), Petracek MR (AUTHOR), Greelish JP (AUTHOR), Hoff SJ (AUTHOR), Ball SK (AUTHOR), Mishra V (AUTHOR), Body SC (AUTHOR), Brown NJ (AUTHOR), Pretorius, Mias1 (AUTHOR), Murray, Katherine T (AUTHOR), Yu, Chang (AUTHOR), Byrne, John G (AUTHOR), Billings, Frederic T 4th (AUTHOR), Petracek, Michael R (AUTHOR), Greelish, James P (AUTHOR), Hoff, Steven J (AUTHOR) |
| Source: | Critical Care Medicine. Oct2012, Vol. 40 Issue 10, p2805-2812. 8p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
